An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients

Journal of Research in Medical Sciences

Volumn 18, Issue 2, 2013, Pages 89-93

  Manohar, Suchitra Mustur ^a   Vaikasuvu, Seshadri Reddy ^a   Deepthi, K ^a   Sachan, Alok ^a   Narasimha, Srinivasa Rao Pemmaraju Venkata Lakshmi ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atherogenic index; Dyslipidemia; Hyperglycemia; Malondialdehyde; Oxidative stress

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK FACTOR; SPECTROPHOTOMETRY;

EID: 84875188379     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. HowardBV, RobbinsDC, CowanLD, LeeET, GoOT, WeltyTK. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: The Strong Heart Study. Diabetes Care 1998;21:1258-65.
2. FoxCS, CoadyS, SorliePD, D'Agostino RB Sr, PencinaMJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study. Circulation 2007;115:1544-50.
3. GrundySM, HowardB, Smith S Jr, EckelR, RedbergR, BonowRO. Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002;105:2231-9.
4. RamachandranA, MaryS, YamunaA, MurugesanN, SnehalathaC. High Prevalence of Diabetes and Cardiovascular Risk Factors Associated With Urbanization in India. Diabetes Care 2008;31:893-8.
5. GargA, GrundySM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153-69.
6. KimmH, LeeSW, LeeHS, ShimKW, ChoCY, YunJE, et al. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin-Usefulness of lipid ratios in Korean men and women. Circ J 2010;74:931-7.
7. McLaughlinT, ReavenG, AbbasiF, LamendolaC, SaadM, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005;96:399-404.
8. McLaughlinT, AbbasiF, ChealK, ChuJ, LamendolaC, ReavenG. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-9.
9. Executive Summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult(Adult Treatment Panel III). JAMA 2001;285:2486-97.
10. CuiY, BlumenthalRS, FlawsJA, WhitemanMK, LangenbergP, Bachorik PS, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001;161:1413-9.
11. LiuJ, SemposC, DonahueRP, DornJ, TrevisanM, GrundySM. Joint Distribution of Non-HDL-C and LDL Cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005;28:1916-21.
12. HermansMP, AhnSA, RousseauMF. Log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males. Cardiovasc Diabetol 2010;9:88.
13. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000;49:27-9.
14. Pfaffly JR. Review on diabetic complications. Free Radic Biol Med 2001;77:222.
15. Hong-zhi P, ZhangL, Mei-yi G, Hong Sui, Hui Li, Wei-hua Wu, et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 2010;47:S71-6.
16. BonfantiG, CeolinRB, ValcorteT, De BonaKS, Leidiane de Lucca, Gonçalves TL, et al. δ-Aminolevulinate dehydratase activity in type 2 diabetic patients and its association with lipid profile and oxidative stress. Clin Biochem 2011;44:1105-1109.
17. NarasimhanS, GokulakrishnanK, SampathkumarR, FarooqS, RavikumarR, MohanV, et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease(NAFLD) in subjects with and without type2 diabetes. Clin Biochem 2010;43:815-21.
18. MorielP, PlavnikFL, ZanellaMT, BertolamiMC, AbdallaDS. Lipid peroxidation and antioxidants in hyperlipidemia and hypertension. Biol Res 2000;33:105-12.
19. FriedewaldWT, LevyRI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. SangeethaP, DasU, KoratkarR, SuryaprabhaP. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990;8:15-9.
21. BenzieIF, StrainJJ. The ferric reducing ability of plasma(FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-6.
22. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
23. PasaogluH, SancakB, BukanN. Lipid peroxidation and resistance to oxidation in patients with type2 diabetes mellitus. Tohoku J Exp Med 2004;203:211-8.
24. WhitingPH, KalansooriyaA, HolbrookI, HaddadF, JenningsPE. The relationship between chronic glycaemic control and oxidative stress in type2 diabetes mellitus. Br J Biomed Sci 2008;65:71-4.
25. Temelkova-KurktschievT, HanefeldM. The lipid triad in type2 diabetes-prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type2 diabetes. Exp Clin Endocrinol Diabetes 2004;112:75-9.
26. HanakV, MunozJ, TeagueJ, StanleyA, BittnerV. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotypeB. Am J Cardiol 2004;94:219-22.
27. DobiasovaM. Atherogenic Index of Plasma[Log(Triglycerides/HDL-C Cholesterol)]: Theoretical and Practical Implications. Clin Chem 2004;50:1113-5.
28. RaoBR, ParineethaPB, RamanVV. Study on Correlations Between Glycated Haemoglobin, Lipid Profi les and Blood Glucose Levels in Type2 Diabetics Living at Moderate High Altitude. International Medical journal Malaysia 2010;9:39-44.